Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.30 |
| ▸ | CA12 | O43570 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA9 | Q16790 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3815344 | 1.00 | DNM1 (0.31) | DNM1ALDH1A1ALDH2CA12CA1 | |
| Hydrochloric Acid SCHEMBL22771741 | 0.97 | DNM1 (0.33) | DNM1 | |
| Hydrochloric Acid SCHEMBL22771743 | 0.97 | DNM1 (0.33) | DNM1 | |
| SCHEMBL20194379 | 0.93 | DNM1 (0.42) | DNM1CA12CA1CA9TSHR | |
| SCHEMBL21148311 | 0.92 | DNM1 (0.40) | DNM1CA12CA1CA9TSHR | |
| Hydrochloric Acid SCHEMBL22771750 | 0.90 | DNM1 (0.42) | DNM1CA12CA1CA9TSHR | |
| Hydrochloric Acid SCHEMBL22771748 | 0.90 | DNM1 (0.42) | DNM1CA12CA1CA9TSHR | |
| SCHEMBL21741896 | 0.90 | DNM1 (0.44) | DNM1CA12CA1CA9TSHR | |
| SCHEMBL5403187 | 0.90 | CA12 (0.30) | CA12CA1CA9 | |
| SCHEMBL5403190 | 0.90 | CA12 (0.30) | CA12CA1CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1296930-B1 | METHOD FOR PRODUCING ALKYLAMINES | BASF SE (DE) | 2009-08-19 | — | — | EP | disclosed |
| US-7161039-B2 | Method and device for producing ethylamine and butylamine | BASF AKTIENGESELLSCHAFT (DE) | 2007-01-09 | — | — | US | disclosed |
| EP-1238964-B1 | Process for preparing n-butylamines | BASF AG (DE) | 2006-10-18 | — | — | EP | disclosed |
| EP-1682475-A1 | METHOD FOR PRODUCING N-BUTYRALDEHYDE | BASF AKTIENGESELLSCHAFT (DE) | 2006-07-26 | — | — | EP | disclosed |
| US-20050124832-A1 | Method and device for producing ethylamine and butylamine | BASF AKTIENGESELLSCHAFT (DE) | 2005-06-09 | — | — | US | disclosed |
| WO-2005042457-A1 | METHOD FOR PRODUCING N-BUTYRALDEHYDE | BASF AKTIENGESELLSCHAFT (DE) | 2005-05-12 | — | — | WO | disclosed |
| EP-1502912-A1 | Process for preparing n-butylamines | BASF AKTIENGESELLSCHAFT (DE) | 2005-02-02 | — | — | EP | disclosed |
| EP-1502911-A1 | Process for the preparation of n-butenylamines | BASF AKTIENGESELLSCHAFT (DE) | 2005-02-02 | — | — | EP | disclosed |
| EP-1498408-A1 | Process for preparing n-butenylamines | BASF AKTIENGESELLSCHAFT (DE) | 2005-01-19 | — | — | EP | disclosed |
| EP-1448510-A1 | METHOD AND DEVICE FOR PRODUCING ETHYLAMINE AND BUTYLAMINE | BASF AKTIENGESELLSCHAFT (DE) | 2004-08-25 | — | — | EP | disclosed |
| US-6576796-B1 | Process for the preparation of alkylamines | BASF AKTIENGESELLSCHAFT (DE) | 2003-06-10 | — | — | US | disclosed |
| WO-2003042149-A1 | METHOD FOR PRODUCTION OF N-BUTYRALDEHYDE AND N-BUTANOL FROM 1,3-BUTADIENE-CONTAINING HYDROCARBON STREAMS | BASF AKTIENGESELLSCHAFT (DE) | 2003-05-22 | — | — | WO | disclosed |
| WO-2003042157-A1 | METHOD AND DEVICE FOR PRODUCING ETHYLAMINE AND BUTYLAMINE | BASF AKTIENGESELLSCHAFT (DE) | 2003-05-22 | — | — | WO | disclosed |
| EP-1296930-A2 | METHOD FOR PRODUCING ALKYLAMINES | BASF AKTIENGESELLSCHAFT (DE) | 2003-04-02 | — | — | EP | disclosed |
| US-6492558-B2 | PREPARATION OF N-BUTYLAMINES FROM N-BUTENYLAMINES WHICH ARE ARE PREPARED BY REACTING 1,3-BUTADIENE IN THE FORM OF A 1,3-BUTADIENE-CONTAINING MIXTURE OBTAINED DURING THE CRACKING OF PETROLEUM FRACTIONS | BASF AKTIENGESELLSCHAFT (DE) | 2002-12-10 | — | — | US | disclosed |
| US-20020169319-A1 | Preparation of n-butylamines | BASF AKTIENGESELLSCHAFT (DE) | 2002-11-14 | — | — | US | disclosed |
| EP-1238964-A1 | Process for preparing n-butylamines and n-butenylamines | BASF AKTIENGESELLSCHAFT (DE) | 2002-09-11 | — | — | EP | disclosed |
| WO-2002000597-A2 | METHOD FOR PRODUCING ALKYLAMINES | BASF AKTIENGESELLSCHAFT (DE) | 2002-01-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020169319-A1 | Preparation of n-butylamines | HNMT, PNMT, LIPG | DNM1 4213/4885ALDH1A1 1385/4885ALDH2 1267/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.